The Recombinant DNA Technology Market is experiencing a steady growth with a Compound Annual Growth Rate (CAGR) of 7.6% in the forecast period from 2024 to 2031. This technology involves the manipulation of DNA to create new combinations of genetic material, leading to the development of innovative products in various industries. The increasing demand for personalized medicine, advancements in biotechnology, and rising investments in research and development are driving the growth of the market. Key players in the industry are focusing on collaborations, partnerships, and acquisitions to expand their product offerings and strengthen their market presence. With the ongoing advancements in technology and increasing applications of recombinant DNA, the market is expected to continue its growth trajectory in the coming years.